Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway
Background Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysr...
Saved in:
| Published in | Cardiovascular diabetology Vol. 21; no. 1; pp. 1 - 15 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
11.10.2022
BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1475-2840 1475-2840 |
| DOI | 10.1186/s12933-022-01643-0 |
Cover
| Abstract | Background
Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysregulation can produce pathological effects on diabetic hearts. Neuregulin-4 (Nrg4) is an adipokine that exerts protective effects against metabolic disorders and insulin resistance. The aim of this study was to explore whether Nrg4 could ameliorate DM-induced myocardial injury by regulating autophagy.
Methods
Four weeks after the establishment of a model of type 1 diabetes in mice, the mice received Nrg4 treatment (with or without an autophagy inhibitor) for another 4 weeks. The cardiac functions, histological structures and cardiomyocyte apoptosis were investigated. Autophagy-related protein levels along with related signalling pathways that regulate autophagy were evaluated. In addition, the effects of Nrg4 on autophagy were also determined in cultured primary cardiomyocytes.
Results
Nrg4 alleviated myocardial injury both in vivo and in vitro. The autophagy level was decreased in type 1 diabetic mice, and Nrg4 intervention reactivated autophagy. Furthermore, Nrg4 intervention was found to activate autophagy via the AMPK/mTOR signalling pathway. Moreover, when autophagy was suppressed or the AMPK/mTOR pathway was inhibited, the beneficial effects of Nrg4 were diminished.
Conclusion
Nrg4 intervention attenuated diabetic cardiomyopathy by promoting autophagy in type 1 diabetic mice. Additionally, Nrg4 induced autophagy via the AMPK/mTOR signalling pathway. |
|---|---|
| AbstractList | Background
Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysregulation can produce pathological effects on diabetic hearts. Neuregulin-4 (Nrg4) is an adipokine that exerts protective effects against metabolic disorders and insulin resistance. The aim of this study was to explore whether Nrg4 could ameliorate DM-induced myocardial injury by regulating autophagy.
Methods
Four weeks after the establishment of a model of type 1 diabetes in mice, the mice received Nrg4 treatment (with or without an autophagy inhibitor) for another 4 weeks. The cardiac functions, histological structures and cardiomyocyte apoptosis were investigated. Autophagy-related protein levels along with related signalling pathways that regulate autophagy were evaluated. In addition, the effects of Nrg4 on autophagy were also determined in cultured primary cardiomyocytes.
Results
Nrg4 alleviated myocardial injury both in vivo and in vitro. The autophagy level was decreased in type 1 diabetic mice, and Nrg4 intervention reactivated autophagy. Furthermore, Nrg4 intervention was found to activate autophagy via the AMPK/mTOR signalling pathway. Moreover, when autophagy was suppressed or the AMPK/mTOR pathway was inhibited, the beneficial effects of Nrg4 were diminished.
Conclusion
Nrg4 intervention attenuated diabetic cardiomyopathy by promoting autophagy in type 1 diabetic mice. Additionally, Nrg4 induced autophagy via the AMPK/mTOR signalling pathway. Background Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysregulation can produce pathological effects on diabetic hearts. Neuregulin-4 (Nrg4) is an adipokine that exerts protective effects against metabolic disorders and insulin resistance. The aim of this study was to explore whether Nrg4 could ameliorate DM-induced myocardial injury by regulating autophagy. Methods Four weeks after the establishment of a model of type 1 diabetes in mice, the mice received Nrg4 treatment (with or without an autophagy inhibitor) for another 4 weeks. The cardiac functions, histological structures and cardiomyocyte apoptosis were investigated. Autophagy-related protein levels along with related signalling pathways that regulate autophagy were evaluated. In addition, the effects of Nrg4 on autophagy were also determined in cultured primary cardiomyocytes. Results Nrg4 alleviated myocardial injury both in vivo and in vitro. The autophagy level was decreased in type 1 diabetic mice, and Nrg4 intervention reactivated autophagy. Furthermore, Nrg4 intervention was found to activate autophagy via the AMPK/mTOR signalling pathway. Moreover, when autophagy was suppressed or the AMPK/mTOR pathway was inhibited, the beneficial effects of Nrg4 were diminished. Conclusion Nrg4 intervention attenuated diabetic cardiomyopathy by promoting autophagy in type 1 diabetic mice. Additionally, Nrg4 induced autophagy via the AMPK/mTOR signalling pathway. Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysregulation can produce pathological effects on diabetic hearts. Neuregulin-4 (Nrg4) is an adipokine that exerts protective effects against metabolic disorders and insulin resistance. The aim of this study was to explore whether Nrg4 could ameliorate DM-induced myocardial injury by regulating autophagy.BACKGROUNDDiabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysregulation can produce pathological effects on diabetic hearts. Neuregulin-4 (Nrg4) is an adipokine that exerts protective effects against metabolic disorders and insulin resistance. The aim of this study was to explore whether Nrg4 could ameliorate DM-induced myocardial injury by regulating autophagy.Four weeks after the establishment of a model of type 1 diabetes in mice, the mice received Nrg4 treatment (with or without an autophagy inhibitor) for another 4 weeks. The cardiac functions, histological structures and cardiomyocyte apoptosis were investigated. Autophagy-related protein levels along with related signalling pathways that regulate autophagy were evaluated. In addition, the effects of Nrg4 on autophagy were also determined in cultured primary cardiomyocytes.METHODSFour weeks after the establishment of a model of type 1 diabetes in mice, the mice received Nrg4 treatment (with or without an autophagy inhibitor) for another 4 weeks. The cardiac functions, histological structures and cardiomyocyte apoptosis were investigated. Autophagy-related protein levels along with related signalling pathways that regulate autophagy were evaluated. In addition, the effects of Nrg4 on autophagy were also determined in cultured primary cardiomyocytes.Nrg4 alleviated myocardial injury both in vivo and in vitro. The autophagy level was decreased in type 1 diabetic mice, and Nrg4 intervention reactivated autophagy. Furthermore, Nrg4 intervention was found to activate autophagy via the AMPK/mTOR signalling pathway. Moreover, when autophagy was suppressed or the AMPK/mTOR pathway was inhibited, the beneficial effects of Nrg4 were diminished.RESULTSNrg4 alleviated myocardial injury both in vivo and in vitro. The autophagy level was decreased in type 1 diabetic mice, and Nrg4 intervention reactivated autophagy. Furthermore, Nrg4 intervention was found to activate autophagy via the AMPK/mTOR signalling pathway. Moreover, when autophagy was suppressed or the AMPK/mTOR pathway was inhibited, the beneficial effects of Nrg4 were diminished.Nrg4 intervention attenuated diabetic cardiomyopathy by promoting autophagy in type 1 diabetic mice. Additionally, Nrg4 induced autophagy via the AMPK/mTOR signalling pathway.CONCLUSIONNrg4 intervention attenuated diabetic cardiomyopathy by promoting autophagy in type 1 diabetic mice. Additionally, Nrg4 induced autophagy via the AMPK/mTOR signalling pathway. Abstract Background Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of diabetes mellitus (DM). Autophagy is a mechanism that is essential for maintaining normal heart morphology and function, and its dysregulation can produce pathological effects on diabetic hearts. Neuregulin-4 (Nrg4) is an adipokine that exerts protective effects against metabolic disorders and insulin resistance. The aim of this study was to explore whether Nrg4 could ameliorate DM-induced myocardial injury by regulating autophagy. Methods Four weeks after the establishment of a model of type 1 diabetes in mice, the mice received Nrg4 treatment (with or without an autophagy inhibitor) for another 4 weeks. The cardiac functions, histological structures and cardiomyocyte apoptosis were investigated. Autophagy-related protein levels along with related signalling pathways that regulate autophagy were evaluated. In addition, the effects of Nrg4 on autophagy were also determined in cultured primary cardiomyocytes. Results Nrg4 alleviated myocardial injury both in vivo and in vitro. The autophagy level was decreased in type 1 diabetic mice, and Nrg4 intervention reactivated autophagy. Furthermore, Nrg4 intervention was found to activate autophagy via the AMPK/mTOR signalling pathway. Moreover, when autophagy was suppressed or the AMPK/mTOR pathway was inhibited, the beneficial effects of Nrg4 were diminished. Conclusion Nrg4 intervention attenuated diabetic cardiomyopathy by promoting autophagy in type 1 diabetic mice. Additionally, Nrg4 induced autophagy via the AMPK/mTOR signalling pathway. |
| ArticleNumber | 205 |
| Author | Xie, Yanan Guo, Bingyan Li, Fang Wang, Hongchao Wang, Lijie Hu, Fuli Wang, Pengfei |
| Author_xml | – sequence: 1 givenname: Hongchao surname: Wang fullname: Wang, Hongchao organization: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University – sequence: 2 givenname: Lijie surname: Wang fullname: Wang, Lijie organization: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University – sequence: 3 givenname: Fuli surname: Hu fullname: Hu, Fuli organization: Department of Cardiology, Shijiazhuang Great Wall Hospital of Integrated Traditional Chinese and Western Medicine – sequence: 4 givenname: Pengfei surname: Wang fullname: Wang, Pengfei organization: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University – sequence: 5 givenname: Yanan surname: Xie fullname: Xie, Yanan organization: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University – sequence: 6 givenname: Fang surname: Li fullname: Li, Fang organization: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University – sequence: 7 givenname: Bingyan surname: Guo fullname: Guo, Bingyan email: gbyan2008bs@163.com organization: Department of Cardiovascular Medicine, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Laboratory Medicine, The Second Hospital of Hebei Medical University |
| BookMark | eNp9UsFu1DAUjFCRaAs_wCkSFy6htmPHyQWpqoBWFIpQOVsvzkvWq6y92E5R_r7OpgLaQ09-tmfmjZ_nJDuyzmKWvaXkA6V1dRYoa8qyIIwVhFY8VS-yY8qlKFjNydF_9avsJIQtIVTWFT3Oxu84eRym0diC5xAj2gkihrwz0GI0OtfgO-N2s9tD3Mx5O-cHPERjhxym6PYbGOb8zkAeN5iff_vx9Wx3e_MzD2awMI4LbKH-gfl19rKHMeCbh_U0-_X50-3FZXF98-Xq4vy60KLmsdAN0bxjAlpZQa8JA0DsmJZNzdO21RUVmlGsuKR9r5mQpOp7VupaY0ckL0-zq1W3c7BVe2924GflwKjDgfODAp_eNqJilegZQkUoaTgTHYi-J4R1XPI0o3LR-rhq7ad2h51GGz2Mj0Qf31izUYO7U40QvJFlEnj_IODd7wlDVDsTNI4jWHRTUEwyzjgRTCTouyfQrZt8GuIBJWrWEL44YitKexeCx_6vGUrUkga1pkGlNKhDGhRJpPoJSZuY_tAtps34PLVcqSH1sQP6f66eYd0DKvzNEA |
| CitedBy_id | crossref_primary_10_1186_s13062_024_00505_x crossref_primary_10_1016_j_envres_2023_115721 crossref_primary_10_1055_a_2399_1174 crossref_primary_10_2147_JIR_S492115 crossref_primary_10_3389_fphys_2022_1106380 crossref_primary_10_1007_s00125_025_06385_8 crossref_primary_10_20517_jca_2024_01 crossref_primary_10_1007_s11010_023_04909_7 crossref_primary_10_1016_j_celrep_2025_115251 crossref_primary_10_1210_endrev_bnad012 crossref_primary_10_31083_j_fbe1502014 crossref_primary_10_1016_j_gde_2023_102046 crossref_primary_10_1186_s12933_023_02078_x crossref_primary_10_3390_biomedicines12112608 crossref_primary_10_1186_s13098_023_01061_6 crossref_primary_10_1016_j_ejmech_2023_116117 crossref_primary_10_1007_s11596_023_2727_4 crossref_primary_10_1016_j_intimp_2024_112338 crossref_primary_10_1152_physiol_00018_2023 crossref_primary_10_1186_s12872_023_03239_2 crossref_primary_10_1016_j_biopha_2024_116790 crossref_primary_10_1016_j_prp_2024_155225 crossref_primary_10_1111_1753_0407_13511 crossref_primary_10_1186_s13098_024_01466_x crossref_primary_10_1007_s13410_024_01420_7 crossref_primary_10_1016_j_intimp_2024_113301 crossref_primary_10_1002_jcb_30428 crossref_primary_10_3390_ph18010134 crossref_primary_10_1016_j_biopha_2023_115669 crossref_primary_10_1186_s13578_023_01097_1 crossref_primary_10_1016_j_metabol_2023_155709 crossref_primary_10_1111_apha_14202 crossref_primary_10_1002_jcb_30634 crossref_primary_10_3390_biomedicines11030662 crossref_primary_10_1007_s11033_023_09050_8 crossref_primary_10_1016_j_antiviral_2022_105482 crossref_primary_10_1080_08916934_2024_2351872 crossref_primary_10_1111_1440_1681_13846 crossref_primary_10_1097_CM9_0000000000003352 crossref_primary_10_3389_fphar_2024_1407883 crossref_primary_10_1039_D2FO03871D crossref_primary_10_1016_j_medidd_2024_100188 crossref_primary_10_1186_s13008_024_00124_y crossref_primary_10_2337_dbi23_0005 |
| Cites_doi | 10.1016/j.bbrc.2016.11.091 10.1016/j.bbrc.2019.04.110 10.1016/j.yjmcc.2011.07.010 10.1371/journal.pone.0251822 10.1016/j.cyto.2018.10.007 10.1016/j.molmed.2021.06.012 10.1007/s10557-020-06968-0 10.1042/CS20160491 10.2337/db21-0064 10.1038/ncb2152 10.1161/CIRCRESAHA.118.311371 10.1111/eci.13206 10.2337/dci19-0074 10.1016/j.mce.2017.03.029 10.1186/s12933-018-0684-1 10.3390/ijms222312960 10.1536/ihj.18-654 10.1007/s11154-021-09640-6 10.1038/s41419-020-2316-4 10.1111/ijcp.14555 10.1007/978-981-15-4272-5_17 10.1016/j.bbamcr.2019.01.013 10.1038/aps.2017.92 10.1111/eci.13306 10.1016/j.arr.2021.101338 10.1016/0002-9149(76)90491-4 10.1002/oby.21757 10.1093/eurheartj/ehv134 10.1016/j.ejphar.2021.174142 10.1161/CIRCRESAHA.117.311586 10.1186/s12933-020-01188-0 10.1155/2018/6974191 10.1002/jcb.28882 10.1002/oby.22595 10.14715/cmb/2022.68.1.12 10.1177/1535370219839643 10.1016/j.jnutbio.2021.108628 10.1016/j.molmet.2017.03.016 10.1111/acel.12876 10.1038/nm.3713 10.1038/srep44265 10.1530/EC-19-0175 10.1186/s12933-020-01041-4 10.7150/ijbs.29680 10.1155/2019/9030563 10.1016/j.ejphar.2020.173350 10.1186/s13098-020-00550-2 10.1007/978-1-4939-7595-2_8 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2022 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022. The Author(s). |
| Copyright_xml | – notice: The Author(s) 2022 – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022. The Author(s). |
| DBID | C6C AAYXX CITATION 3V. 7T5 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12933-022-01643-0 |
| DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Immunology Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Local Electronic Collection Information ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1475-2840 |
| EndPage | 15 |
| ExternalDocumentID | oai_doaj_org_article_265f2ea60109425da5ff002d47400134 PMC9554973 10_1186_s12933_022_01643_0 |
| GeographicLocations | Beijing China United States--US China |
| GeographicLocations_xml | – name: China – name: Beijing China – name: United States--US |
| GrantInformation_xml | – fundername: Natural Science Foundation of Hebei Province grantid: H202006504 funderid: http://dx.doi.org/10.13039/501100003787 – fundername: Medical Science Research Project of Hebei Province grantid: 20221063 – fundername: National Natural Science Foundation of China grantid: 81400217 funderid: http://dx.doi.org/10.13039/501100001809 – fundername: ; grantid: 20221063 – fundername: ; grantid: 81400217 – fundername: ; grantid: H202006504 |
| GroupedDBID | --- 0R~ 29B 2WC 53G 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX ALIPV CITATION 3V. 7T5 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c584t-c90c4d25ab76afc02aaeed2c7984fc0bc615c21e6471ffc25706ff23c8ced0743 |
| IEDL.DBID | DOA |
| ISSN | 1475-2840 |
| IngestDate | Wed Aug 27 01:32:04 EDT 2025 Thu Aug 21 18:39:16 EDT 2025 Fri Sep 05 05:37:49 EDT 2025 Tue Aug 19 02:50:18 EDT 2025 Tue Jul 01 04:19:57 EDT 2025 Thu Apr 24 22:53:41 EDT 2025 Sat Sep 06 07:28:52 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Diabetic cardiomyopathy Signalling pathway Autophagy Neuregulin-4 |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c584t-c90c4d25ab76afc02aaeed2c7984fc0bc615c21e6471ffc25706ff23c8ced0743 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://doaj.org/article/265f2ea60109425da5ff002d47400134 |
| PQID | 2725829044 |
| PQPubID | 42570 |
| PageCount | 15 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_265f2ea60109425da5ff002d47400134 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9554973 proquest_miscellaneous_2724240525 proquest_journals_2725829044 crossref_primary_10_1186_s12933_022_01643_0 crossref_citationtrail_10_1186_s12933_022_01643_0 springer_journals_10_1186_s12933_022_01643_0 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2022-10-11 |
| PublicationDateYYYYMMDD | 2022-10-11 |
| PublicationDate_xml | – month: 10 year: 2022 text: 2022-10-11 day: 11 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London |
| PublicationTitle | Cardiovascular diabetology |
| PublicationTitleAbbrev | Cardiovasc Diabetol |
| PublicationYear | 2022 |
| Publisher | BioMed Central BMC |
| Publisher_xml | – name: BioMed Central – name: BMC |
| References | M Li (1643_CR39) 2019; 8 S Dewanjee (1643_CR24) 2021; 68 J Shi (1643_CR27) 2019; 11 B Zhu (1643_CR25) 2020; 884 HC Kenny (1643_CR2) 2019; 124 T Xu (1643_CR45) 2019; 2019 B Wu (1643_CR26) 2017; 2017 T De Munck (1643_CR38) 2021; 16 J Kim (1643_CR50) 2011; 13 KA Escobar (1643_CR48) 2019; 18 H Tutunchi (1643_CR43) 2021; 75 R Li (1643_CR28) 2017; 25 N Ghosh (1643_CR6) 2018; 17 A Zech (1643_CR18) 2020; 1867 L Wang (1643_CR5) 2021; 20 F Díaz-Sáez (1643_CR11) 2021; 22 P Yan (1643_CR15) 2020; 12 Y Zhang (1643_CR23) 2017; 448 M Tate (1643_CR1) 2017; 131 C Lin (1643_CR49) 2017; 482 C Jentzsch (1643_CR29) 2012; 52 QQ Wu (1643_CR19) 2020; 11 PM Seferović (1643_CR4) 2015; 36 ÁF Fernández (1643_CR36) 2018; 1731 M Packer (1643_CR47) 2020; 19 X Li (1643_CR21) 2019; 514 F Yang (1643_CR22) 2019; 15 G Jia (1643_CR3) 2018; 122 A Gavaldà-Navarro (1643_CR37) 2022; 23 LE Teichholz (1643_CR32) 1976; 37 Y Li (1643_CR41) 2021; 70 W Wang (1643_CR12) 2019; 244 Z Chen (1643_CR9) 2017; 6 P Yan (1643_CR13) 2019; 113 F Yang (1643_CR42) 2021; 93 GX Wang (1643_CR10) 2014; 20 Z Yang (1643_CR44) 2022; 68 P Yan (1643_CR14) 2018; 2018 S Guo (1643_CR31) 2018; 39 J Du (1643_CR34) 2020; 1207 Y Ding (1643_CR33) 2019; 120 L Liberale (1643_CR8) 2020; 50 M Blüher (1643_CR40) 2019; 27 T Sato (1643_CR7) 2019; 60 M Packer (1643_CR46) 2020; 43 L Sun (1643_CR35) 2021; 903 N Mizushima (1643_CR17) 2021; 27 MZ Kocak (1643_CR16) 2020; 50 T Ni (1643_CR20) 2020; 34 L Wang (1643_CR30) 2017; 7 |
| References_xml | – volume: 482 start-page: 665 issue: 4 year: 2017 ident: 1643_CR49 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2016.11.091 – volume: 514 start-page: 1 issue: 1 year: 2019 ident: 1643_CR21 publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2019.04.110 – volume: 52 start-page: 13 issue: 1 year: 2012 ident: 1643_CR29 publication-title: J Mol Cell Cardiol doi: 10.1016/j.yjmcc.2011.07.010 – volume: 16 start-page: e0251822 issue: 5 year: 2021 ident: 1643_CR38 publication-title: PLoS ONE doi: 10.1371/journal.pone.0251822 – volume: 113 start-page: 356 year: 2019 ident: 1643_CR13 publication-title: Cytokine doi: 10.1016/j.cyto.2018.10.007 – volume: 27 start-page: 835 issue: 9 year: 2021 ident: 1643_CR17 publication-title: Trends Mol Med doi: 10.1016/j.molmed.2021.06.012 – volume: 34 start-page: 291 issue: 3 year: 2020 ident: 1643_CR20 publication-title: Cardiovasc Drugs Ther doi: 10.1007/s10557-020-06968-0 – volume: 131 start-page: 897 issue: 10 year: 2017 ident: 1643_CR1 publication-title: Clin Sci (Lond) doi: 10.1042/CS20160491 – volume: 70 start-page: 2213 issue: 10 year: 2021 ident: 1643_CR41 publication-title: Diabetes doi: 10.2337/db21-0064 – volume: 13 start-page: 132 issue: 2 year: 2011 ident: 1643_CR50 publication-title: Nat Cell Biol doi: 10.1038/ncb2152 – volume: 124 start-page: 121 issue: 1 year: 2019 ident: 1643_CR2 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.118.311371 – volume: 50 start-page: e13206 issue: 3 year: 2020 ident: 1643_CR16 publication-title: Eur J Clin Invest doi: 10.1111/eci.13206 – volume: 43 start-page: 508 issue: 3 year: 2020 ident: 1643_CR46 publication-title: Diabetes Care doi: 10.2337/dci19-0074 – volume: 448 start-page: 98 year: 2017 ident: 1643_CR23 publication-title: Mol Cell Endocrinol doi: 10.1016/j.mce.2017.03.029 – volume: 17 start-page: 43 issue: 1 year: 2018 ident: 1643_CR6 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-018-0684-1 – volume: 22 start-page: 12960 issue: 23 year: 2021 ident: 1643_CR11 publication-title: Int J Mol Sci doi: 10.3390/ijms222312960 – volume: 60 start-page: 1 issue: 1 year: 2019 ident: 1643_CR7 publication-title: Int Heart J doi: 10.1536/ihj.18-654 – volume: 23 start-page: 31 issue: 1 year: 2022 ident: 1643_CR37 publication-title: Rev Endocr Metab Disord doi: 10.1007/s11154-021-09640-6 – volume: 11 start-page: 160 issue: 3 year: 2020 ident: 1643_CR19 publication-title: Cell Death Dis doi: 10.1038/s41419-020-2316-4 – volume: 75 start-page: e14555 issue: 10 year: 2021 ident: 1643_CR43 publication-title: Int J Clin Pract doi: 10.1111/ijcp.14555 – volume: 1207 start-page: 229 year: 2020 ident: 1643_CR34 publication-title: Adv Exp Med Biol doi: 10.1007/978-981-15-4272-5_17 – volume: 1867 start-page: 118432 issue: 3 year: 2020 ident: 1643_CR18 publication-title: Biochim Biophys Acta Mol Cell Res doi: 10.1016/j.bbamcr.2019.01.013 – volume: 39 start-page: 195 issue: 2 year: 2018 ident: 1643_CR31 publication-title: Acta Pharmacol Sin doi: 10.1038/aps.2017.92 – volume: 50 start-page: e13306 year: 2020 ident: 1643_CR8 publication-title: Eur J Clin Invest. doi: 10.1111/eci.13306 – volume: 68 start-page: 101338 year: 2021 ident: 1643_CR24 publication-title: Ageing Res Rev doi: 10.1016/j.arr.2021.101338 – volume: 37 start-page: 7 issue: 1 year: 1976 ident: 1643_CR32 publication-title: Am J Cardiol doi: 10.1016/0002-9149(76)90491-4 – volume: 25 start-page: 561 issue: 3 year: 2017 ident: 1643_CR28 publication-title: Obes (Silver Spring) doi: 10.1002/oby.21757 – volume: 36 start-page: 1718 issue: 27 year: 2015 ident: 1643_CR4 publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv134 – volume: 11 start-page: 5501 issue: 9 year: 2019 ident: 1643_CR27 publication-title: Am J Transl Res – volume: 903 start-page: 174142 year: 2021 ident: 1643_CR35 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2021.174142 – volume: 122 start-page: 624 issue: 4 year: 2018 ident: 1643_CR3 publication-title: Circ Res doi: 10.1161/CIRCRESAHA.117.311586 – volume: 20 start-page: 2 issue: 1 year: 2021 ident: 1643_CR5 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01188-0 – volume: 2018 start-page: 6974191 year: 2018 ident: 1643_CR14 publication-title: Dis Markers doi: 10.1155/2018/6974191 – volume: 120 start-page: 16025 issue: 9 year: 2019 ident: 1643_CR33 publication-title: J Cell Biochem doi: 10.1002/jcb.28882 – volume: 27 start-page: 1555 issue: 10 year: 2019 ident: 1643_CR40 publication-title: Obes (Silver Spring) doi: 10.1002/oby.22595 – volume: 68 start-page: 89 issue: 1 year: 2022 ident: 1643_CR44 publication-title: Cell Mol Biol (Noisy-le-grand) doi: 10.14715/cmb/2022.68.1.12 – volume: 244 start-page: 565 issue: 7 year: 2019 ident: 1643_CR12 publication-title: Exp Biol Med (Maywood) doi: 10.1177/1535370219839643 – volume: 93 start-page: 108628 year: 2021 ident: 1643_CR42 publication-title: J Nutr Biochem doi: 10.1016/j.jnutbio.2021.108628 – volume: 6 start-page: 863 issue: 8 year: 2017 ident: 1643_CR9 publication-title: Mol Metab doi: 10.1016/j.molmet.2017.03.016 – volume: 18 start-page: e12876 issue: 1 year: 2019 ident: 1643_CR48 publication-title: Aging Cell doi: 10.1111/acel.12876 – volume: 20 start-page: 1436 issue: 12 year: 2014 ident: 1643_CR10 publication-title: Nat Med doi: 10.1038/nm.3713 – volume: 7 start-page: 44265 year: 2017 ident: 1643_CR30 publication-title: Sci Rep doi: 10.1038/srep44265 – volume: 2017 start-page: 3764370 year: 2017 ident: 1643_CR26 publication-title: Biomed Res Int – volume: 8 start-page: 728 issue: 6 year: 2019 ident: 1643_CR39 publication-title: Endocr Connect doi: 10.1530/EC-19-0175 – volume: 19 start-page: 62 issue: 1 year: 2020 ident: 1643_CR47 publication-title: Cardiovasc Diabetol doi: 10.1186/s12933-020-01041-4 – volume: 15 start-page: 1010 issue: 5 year: 2019 ident: 1643_CR22 publication-title: Int J Biol Sci doi: 10.7150/ijbs.29680 – volume: 2019 start-page: 9030563 year: 2019 ident: 1643_CR45 publication-title: Oxid Med Cell Longev doi: 10.1155/2019/9030563 – volume: 884 start-page: 173350 year: 2020 ident: 1643_CR25 publication-title: Eur J Pharmacol doi: 10.1016/j.ejphar.2020.173350 – volume: 12 start-page: 42 year: 2020 ident: 1643_CR15 publication-title: Diabetol Metab Syndr doi: 10.1186/s13098-020-00550-2 – volume: 1731 start-page: 73 year: 2018 ident: 1643_CR36 publication-title: Methods Mol Biol doi: 10.1007/978-1-4939-7595-2_8 |
| SSID | ssj0017861 |
| Score | 2.5371165 |
| Snippet | Background
Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious... Background Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious... Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious complication of... Abstract Background Diabetic cardiomyopathy is characterized by left ventricle dysfunction, cardiomyocyte apoptosis, and interstitial fibrosis and is a serious... |
| SourceID | doaj pubmedcentral proquest crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 1 |
| SubjectTerms | Angiology Apoptosis Autophagy Cardiology Cardiomyocytes Cardiomyopathy Cardiovascular disease Collagen Diabetes Diabetes mellitus (insulin dependent) Diabetic cardiomyopathy Fibrosis Glucose Heart failure Insulin Insulin resistance Medical research Medicine Medicine & Public Health Metabolic disorders Metabolism Neuregulin Neuregulin-4 Signal transduction Signalling pathway Software TOR protein Ventricle |
| SummonAdditionalLinks | – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Na9wwEBXpBkovpZ_UTVpU6K01a8v6sA-lJCUhtOw2hARyE7IkJwuJnWx2W_zvOyPbGxxojrYlZHukmSfP-D1CPheOZV4ZGQMYzmKeeRHnwqhYloVnYHOXedwozuby6Iz_PBfnW2Q-_AuDZZWDTwyO2jUWv5FPmWICk36cf7-5jVE1CrOrg4SG6aUV3LdAMfaEbINLFsmEbO8fzI9PNnkFlct0-HUml9M7jHaYx8TyBIjNcTIKT4HFfwQ9HxZOPsiehqB0-II879Ek3evM_5Js-foVeTrr8-WvyRVyb6Da_KKOOUUqzXqN4JJ2n1wXltpQj3rdNihN3NKypctOnR7Go2aNtAPmoqV_FoYCVKR7s-Nf0-vT3ycUCz9MIPSm2PWvad-Qs8OD0x9Hca-vEFuAHavYFonljglTKmkqmzBjIGIyq4qcw2FpAe1YlnoJAayqLOrdyapimc2tdwg93pJJ3dT-HaGiTEySOqdUCZAsqwwgO1_41Dshwd36iKTDa9W2Jx9HDYwrHTYhudSdKTSYQgdT6CQiXzZ9bjrqjUdb76O1Ni2RNjucaJYXul-FmklRMW9wE1qAs3JGVBWEBMcVRyzMI7I72Fr3a_lO38-8iHzaXIZViKkVU_tmHdpwwEaCiYio0RwZ3dD4Sr24DHzeBUC6QmUR-TrMpvvB___A7x-_1x3yjOG8xuKbdJdMVsu1_wD4aVV-7BfFP5aqGYM priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELaqVkJcEOUhAgUZiRuYJo4fyQFVBVFVoAWEulJvlmM77UrbLGx3gfz7zjjJVqkKJ46JbSX2eDzfZCbfEPKq9DwP2ioGYDhnIg-SFdJqpqoycJC5zwM6ipMv6ngqPp3K0y0ylDvqF_DyVtcO60lNl_O3f362B6Dw76LCF2r_Em0WRiMxyQAsLAMXfifGizCVT1xHFXShsuHHmVvHjYxT5PAfAc-baZM3YqfRJB3dJ_d6LEkPO-Hvkq3QPCB3Jn20_CGZI_MG1pqfNUxQJNJs1ggtaffBdeaoi9moF-0CCxO3tGrpsqtND8-jdo2kA_aspb9mlgJQpIeTb5_3L06-fqeY9mEjnTfFob9t-4hMjz6efDhmfXUF5gB0rJgrUyc8l7bSytYu5daCveROl4WAy8oB1nE8CwrMV107rHan6prnrnDBI_B4TLabRROeECqr1KaZ91pXAMjy2gKuC2XIgpcKDtuQkGxYVuN66nGsgDE30QUplOlEYUAUJorCpAl5vRnzoyPe-Gfv9yitTU8kzY43Fssz0-ug4UrWPFh0QUs4qryVdQ0GwQstEAmLhOwNsjbDRjRcc4nBZgHNLzfNoIMYWLFNWKxjHwHISHKZED3aI6MXGrc0s_PI5l0CoCt1npA3w266fvjfJ_z0f0z4GbnLcfdjgk62R7ZXy3V4DhhrVb2IinMF07MiRg priority: 102 providerName: Scholars Portal – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3da9RAEF-kgvgirVWMbWWFvunSZLMfyWN7WIpytkgLfVs2-6EHbU7au5b8953Z5E5TVPAx2V02yczu_CYz-xtC9mvPy6CtYgCGSybKIFklrWaqqQMHmfsyoKM4_apOLsTnS3k50OTgWZjf4_dFpQ5u0R5hpBETCMB6MnDPn0rYeFGbJ2qyjhjoShWrQzF_HDcyPImffwQqH6dEPoqLJnNzvEleDDiRHvaC3SJPQvuSPJsOkfBtcoWsGlhHftYyQZEks10ibKT9z9SZoy5lml53cyw63NGmozd93XmYj9olEgrY7x29m1kKIJAeTs--HFyfn36jmNJhE1U3xaH3tntFLo4_nU9O2FA5gTkAFAvm6twJz6VttLLR5dxasIXc6boScNk4wDGOF0GBaYrRYSU7FSMvXeWCR1Dxmmy08za8IVQ2uc0L77VuAGyV0QJmC3UogpcKNtKQkWL1WY0baMWxusWVSe5FpUwvCgOiMEkUJs_Ih_WYnz2pxj97H6G01j2REDvdAD0xw_oyXMnIg0X3soZtyFsZI2z2XmiBKFdkZHclazOs0lvDNZcYSBbQ_H7dDOsLgya2DfNl6iMA9UguM6JHOjJ6oHFLO_uRmLprAGu1LjPycaVNvyb_-wu__b_uO-Q5Rz3HNJtil2wsbpZhD5DSonmXlsgD6VkLuQ priority: 102 providerName: Springer Nature |
| Title | Neuregulin-4 attenuates diabetic cardiomyopathy by regulating autophagy via the AMPK/mTOR signalling pathway |
| URI | https://link.springer.com/article/10.1186/s12933-022-01643-0 https://www.proquest.com/docview/2725829044 https://www.proquest.com/docview/2724240525 https://pubmed.ncbi.nlm.nih.gov/PMC9554973 https://doaj.org/article/265f2ea60109425da5ff002d47400134 |
| Volume | 21 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBZtCqWX0id1mi4q9NaKtWU97ONmSQhbNg1pAnsTsiw3C4k3JLst_vedke1tHUh66cXGemBLM_J88oy_IeRTXvLUa6sYgOGUidRLlkmrmSpyz0HmZepxozg_VkfnYraQi79SfWFMWEsP3E7cmCtZcW9x35CDfpVWVhWs4lJogfAlMIHGedxvpjr_gc5U0v8ik6nxLVo19FdiGALYYBYPzFBg6x9AzLsBkne8pMH4HL4gzzvUSCft074kj3z9ijydd37x1-QSOTYwq_yyZoIiZWa9QRBJ20-rS0ddiDu9alaYgrihRUNv2iz0cD9qN0gvYH809OfSUoCEdDI_-Tq-Ovt2SjHAwwbibopdf9nmDTk_PDibHrEujwJzAC_WzOWxEyWXttDKVi7m1oJl5E7nmYDLwgGqcTzxCgxVVTnMa6eqiqcuc75EiPGW7NSr2r8jVBaxjZOy1LoA6JVWFhCcz33iS6ngteojkvTTalxHMo65Li5N2GxkyrSiMCAKE0Rh4oh83va5bik2Hmy9j9LatkR67FAASmM6pTH_UpqI7PWyNt2avTVcc4luZQHVH7fVsNrQhWJrv9qENgIwkOQyInqgI4MHGtbUy4vA250DdMt1GpEvvTb9ufn9A979HwN-T55x1H4MxUn2yM76ZuM_AJpaFyPyWC_0iDyZTGbfZ3DePzg-OYXSqZqOwqKC41xkvwFHdx-e |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxFMYCiwSnMCKvd6HfUCoBaqUNAWhVMptWa_XJVJrlyah8p_iN3ZmbadKJXrr0fE6fszj-8YzniHkbVawxCkjQyDDScgTJ8JUGBXKPHMMZF4kDgPF8YEcHvJvUzHdIP_6b2GwrLL3id5RF7XFd-QDppjApB_nn07_hDg1CrOr_QiNVi1GrjmHkG3-ce8LyPcdY7tfJ5-HYTdVILQAtovQZpHlBRMmV9KUNmLGAE4wq7KUw2ZuAeMti50Et12WFqe8ybJkiU2tKxBw4X9vkdscU4xgP2q6CvBilcq4_zAnlYM5YilmSbH4AZA_jNbAz88IWCO2V8syr-RmPeTtPiD3O65Kt1vlekg2XPWI3Bl32fjH5Bg7e-As-1kVcoqNOqslUlfavtCdWWp9tetJU-Pg44bmDfXrDdZaU7PEpgbmqKF_Z4YCEaXb4x-jwcnk-0-KZSXGtwuneOi5aZ6Qwxt5zk_JZlVX7hmhIo9MFBeFUjkQvqQ0wBtd5mJXCAnO3AUk7h-rtl1rc5ywcax9iJNK3YpCgyi0F4WOAvJ-dcxp29jj2tU7KK3VSmzK7X-oz450Z-OaSVEyZzDEzcAVFkaUJQBOwRVHps0DstXLWneeYq4v9Togb1a7wcYxcWMqVy_9Gg7MSzARELWmI2sXtL6nmv323cIzIIyZSgLyodemy5P__4afX3-tr8nd4WS8r_f3DkYvyD2GOo5lPvEW2VycLd1LYGqL_JU3D0p-3bQ9XgDYAFFr |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELfQJk28ID5FYYCReIOoieOP-LF8VKOjY4JN2pvlOPaotKVT14Ly33PnJIVMgMRjYltOcj7f73Ln3xHySlcs98rKBMBwnvDci6QQViWy1J6BzKvco6M4P5IHp3x2Js5-O8Ufs937kGR7pgFZmur1-KoKrYoXcnyNVgrjj5hWADY1Aad9txBag_u1O5nMvs62kQRVyKw_LPPHkQODFHn7B2DzZqrkjXhpNEPTu-ROhx_ppBX4PXLL1_fJ3ryLkD8gF8i2gfXlF3XCKZJn1huEk7T9ybpw1MUM1MtmicWIG1o2dNXWo4f5qN0g0YA9b-j3haUADulkfnw4vjz5_IViqoeNFN4Uh_6wzUNyOv1w8u4g6SoqJA6AxjpxOnW8YsKWStrgUmYt2EjmlC44XJYO8I1jmZdgskJwWOFOhsByVzhfIdh4RHbqZe0fEyrK1KZZVSlVAgjLgwUs57XPfCUkbLB-RLL-sxrX0Y1j1YsLE92OQppWFAZEYaIoTDoir7djrlqyjX_2fovS2vZEoux4Y7k6N53eGSZFYN6i26lhe6qsCAGMQMUVR_TLR2S_l7XptPfaMMUEBpg5NL_cNoPeYTDF1n65iX04oCHBxIiowRoZPNCwpV58iwzeGkCcVvmIvOlX06_J__7CT_6v-wuyd_x-aj59PDp8Sm4zXPKYiZPtk531auOfAZhal887ffkJTLYYZg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neuregulin-4+attenuates+diabetic+cardiomyopathy+by+regulating+autophagy+via+the+AMPK%2FmTOR+signalling+pathway&rft.jtitle=Cardiovascular+diabetology&rft.au=Hongchao+Wang&rft.au=Lijie+Wang&rft.au=Fuli+Hu&rft.au=Pengfei+Wang&rft.date=2022-10-11&rft.pub=BMC&rft.eissn=1475-2840&rft.volume=21&rft.issue=1&rft.spage=1&rft.epage=15&rft_id=info:doi/10.1186%2Fs12933-022-01643-0&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_265f2ea60109425da5ff002d47400134 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1475-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1475-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1475-2840&client=summon |